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INTRODUCTION
Sinusitis, bronchitis, and bronchial asthma have a com-
mon characteristic, excessive secretion of mucus. The mech-
anism for mucus secretion is mediated by various cyto-
kines, peptides, inflammatory mediators, and mucin genes 
such as up-regulated MUC5AC or MUC8.1)2) According to 
studies on MUC5AC expression, overexpression of MU-
C5AC induced by interleukin (IL)-1β occurs in airway epi-
thelial cells by activation of mitogen-activated protein ki-
nases (MAPKs) and stress-activated protein kinase-1-
cAMP response element-binding pathways in a sequential 
cascade. This finding suggests a treatment strategy for in-
flammatory airway diseases through the control of mucus 
hypersecretion.3) 
Berberine has been extensively studied for its multiple 
biological and pharmacological activities in various diseas-
es, including respiratory diseases. Traditionally, it has been 
used as antifungal, anti-inflammatory, anti-viral agents, 
and also for respiratory disorders. There is some evidence 
to support its use in the treatment of heart failure, malaria, 
diabetes, glaucoma, hypercholesterolemia, diarrhea, tra-
choma, and leishmaniasis.4-6) Berberine has similar phar-
macological effects to clonidine, an α-adrenergic agonist, 
and interacts with an α-adrenergic receptor.7) Moreover, 
berberine inhibits release of TNF-α.8) As MUC5AC expres-
sion is known to be up-regulated by TNF-α, we formulat-
ed a hypothesis that berberine suppressed MUC5AC gene 
expression in human airway epithelial cells. However, there 
is no evidence that berberine can suppress mucin secretion 
in human airway epithelium.
Therefore, the aim of this study was to investigate wheth-
er berberine suppresses IL-1β-induced MUC5AC gene 
expression in human airway epithelial cells and, if so, to 
examine which MAPKs are involved in MUC5AC gene 
suppression.
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ABSTRACT
Objectives：The aim of this study was to investigate whether berberine suppresses interleukin (IL)-1β-induced MUC5AC 
gene expression in human airway epithelial cells and, if so, to determine which mitogen-activated protein kinases (MAPKs) 
are related to MUC5AC gene suppression. Materials and Methods：MUC5AC mRNA and protein levels were measured 
using reverse transcription-polymerase chain reaction (PCR), real-time PCR, and western blot analysis in cultured NCI-H292 
human airway epithelial cells. Results：IL-1β-induced expressions of MUC5AC mRNA and protein were significantly 
suppressed in cells pretreated with 25 µM of berberine. Levels of MAPK proteins were determined by western blot analysis 
after pretreatment with 25 µM berberine. Berberine suppressed phosphorylation of extracellular signal-regulated kinase (ERK) 
and p38 MAPK, but there was no change in the expression of JNK. Suppression of IL-1β-induced MUC5AC mRNA was also 
observed in cells pretreated with ERK- or p38 MAPK-specific inhibitors, suggesting that berberine suppresses IL-1β-induced 
expression of MUC5AC mRNA, which involves the ERK- and p38 MAPK-dependent pathways. Conclusion：Berberine 
suppresses IL-1β-induced MUC5AC gene expression in human airway epithelial cells via the ERK- and p38 MAPK-dependent 
pathways; therefore, berberine may be considered as a possible anti-hypersecretory agent for inflammatory airway diseases.
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MATERIALS AND METHODS
Cell culture
NCI-H292 cells were purchased from the American 
Type Culture Collection (Rockville, MD) and cultured in 
Roswell Park Memorial Institute (RPMI) 1640 (Gibco 
BRL, Grand Island, NY) supplemented with 10% fetal 
bovine serum, 2 mM of L-glutamine, penicillin (100 μg/
mL), and streptomycin (100 μg/mL) at 37°C in a humidi-
fied chamber with 95% air and 5% CO2. When cultures 
reached 70-80% confluency, cells were incubated in 
RPMI 1640 medium containing 0.5% fetal bovine serum 
for 24 hours.
Materials
Berberine was purchased from Sigma Co. (St. Louis, MO, 
USA). PD98059 (a specific inhibitor of ERK), and SB203580 
(a specific inhibitor of p38 MAPK) were purchased from 
Calbiochem Biochemicals (San Diego, CA, USA). IL-1β 
was purchased from R&D Systems (Minneapolis, MN, 
USA) and anti-phospho-p44/42 MAPK (Thr202/Tyr204) 
antibody, anti-phospho-p38 MAPK (Thr180/Tyr182) anti-
body, and anti-phospho-SAPK/c-Jun NH2-terminal kinase 
MAPK (Thr183/Tyr185) antibody were purchased from Cell 
Signaling (Beverly, MA, USA). 
Reverse Transcription (RT)-Polymerase Chain 
Reaction (PCR) of MUC5AC mRNA 
Total cellular RNA was isolated from cultured NCI-H292 
cells treated with IL-1β under each condition using Tri-Re-
agent (Molecular Research Center, Cincinnati, OH, USA). 
Total RNA (1 μg/20 μL) was reverse transcribed into cDNA 
using random hexanucleotide primers and Moloney mu-
rine leukemia virus reverse transcriptase (Gibco BRL), and 
MUC5AC cDNA was amplified by PCR using a Perkin-
Elmer Cetus DNA Thermal Cycler (Perkin-Elmer, Nor-
walk, CT, USA) using previously described methods.3) A 
sequence of 5′ primer was CGACAACTACTTCTGCG-
GTGC, and that of 3′ primer was GCACTCATCCTTCCT-
GTCGTT. Amplification of each target gene was confirmed 
by sequencing (dsDNA Cycle Sequencing System ; Gibco 
BRL) of PCR fragments.
Real-time PCR of MUC5AC mRNA
Primers and probes were designed with PerkinElmer 
Life Sciences Prime Express software and purchased from 
PE Biosystems (Foster City, CA, USA). Commercial re-
agents (Taqman PCR Universal PCR Master Mix, Perki-
nElmer Life Sciences) and conditions according to the man-
ufacturer’s protocol were applied. An amount of 1 µg of 
cDNA (reverse transcription mixture) and oligonucle-
otides at a final concentration of 800 nM of primers and 
200 nM of TaqMan hybridization probes were analyzed 
in a 25 µL volume. The real time-PCR probe was labeled 
with carboxyfluoroscein (FAM) at the 5’ end and with a 
quencher carboxytetramethylrhodamine (TARMA) at the 
3’ end. MUC5AC, β2M primers and TaqMan probe were 
designed as follows : MUC5AC (forward : 5’-CAGC-
CACGTCCCCTTCAATA-3’ and reverse : 5’-ACCG-
CATTTGGGCATCC-3’, TaqMan probe 6FAM-CCA-
CCTCCGAGCCCGTCACTGAG-TAMRA), β2M 
(forward : 5’-CGCTCCGTGGCCTTAGC-3’ and reverse : 
5’-GAGTACGCTGGATAGCCTCCA-3’, and Taqman 
probe 6FAM-TGCTCGCGCTACTCTCTCTTTCTGGC-
TAMRA). Real-time PCR was performed on a PerkinEl-
mer Life Sciences ABI PRISM 7700 Sequence Detection 
System using previously described methods.3) Data are ex-
pressed as means±SD. A minimum of at least three inde-
pendent experiments were performed for each measure-
ment. Differences between treatment groups were assessed 
by ANOVA with post hoc test, and the statistical signifi-
cance was accepted for p values ＜0.05.
Western blot analysis 
Cells were scraped into 1 mL of radioimmunoprecipi-
tation assay buffer (1% NP-40, 0.5% sodium deoxycho-
late, 0.1% SDS). Protein concentration was measured by 
bicinchronic acid protein assay using bovine serum albu-
min. Cell lysates were centrifuged and supernatants were 
subjected to Western blot. Each lane was added with 30 
µg of protein, and electrophoresis was performed. Pro-
teins were separated by 8% SDS-PAGE and transferred 
onto a nitrocellulose membrane. Blots were blocked with 
10% non-fat dry milk in Tris-buffered saline with 0.05% 
Tween-20 (TBST) at 4℃ for 12 h and probed with anti-
p-ERK (1 : 1,000), anti-p-p38 MAPK (1 : 1,000), and an-
ti-p-JNK (1 : 1,000) antibody for 4 h at room temperature. 
In addition, expression of MUC5AC protein was assessed 
with anti-MUC5AC antibody (1 : 1,000, Santa Cruz Bio-
technology, Santa Cruz, CA, USA). After washing, blots 
were treated with horseradish peroxidase-conjugated sec-
ondary antibody (Amersham Pharmacia Biotech, Piscat-
away, NJ, USA) diluted to 1 : 5,000 in TBST for 1 h and 
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washed several times. Enhanced chemiluminescence and 
autoradiography were used for detection of bands. Blots were 
stripped and probed with α-tubulin antibody (Santa Cruz 
Biotechnology) to normalize for loading.
Cell proliferation assay 
Cells were plated in 96-well plates at a density of 2,000 
cells/well. After incubation for 16 hours, cells were washed 
with phosphate-buffered saline and incubated for 24 hours 
in serum-free medium containing varying concentrations 
of berberine. Cell proliferation was measured using a Cell 
Titer 96 Aqueous One Solution Proliferation Assay Kit 
(Promega Inc., Madison, WI) using as previously described.3) 
The mean percentage of living cells was calculated as 
follows : [1-(mean O.D. of experimental group/mean O.D. 
of control)]×100. Experiments were performed more 
than 3 times, and statistical significance was accepted for 
p values ＜0.05 through the repeated measures ANOVA 
and multiple comparisons analysis.
RESULTS
Berberine suppresses IL-1β-induced MUC5AC 
mRNA expression
In a previous study, IL-1β maximally induced MUC5AC 
mRNA at a concentration of 10 ng/mL and incubation 
time of 24 h.3) Therefore, we used a 10 ng/mL concentra-
tion of IL-1β and 24 hour incubation time for experiments 
in this study. NCI-H292 cells were pretreated with berber-
ine at concentrations of 0, 5, 25, and 50 µM 1 h before add-
ing 10 ng/mL of IL-1β. After adding IL-1β to the cells, 
RT-PCR and real-time PCR for MUC5AC mRNA expres-
sion was performed. In comparison with the control which 
was not treated with either IL-1β or berberine, the relative 
ratio of MUC5AC mRNA expression at 0, 5, 25, and 50 
μM of berberine was 5.2±0.6, 2.8±0.5, 1.1±0.3, 0.8±
0.3. From 25 μM of berberine, IL-1β-induced MUC5AC 
mRNA expression was significantly suppressed which 
was in a dose-dependent manner (p＜0.05)(Fig. 1A, B). To 
evaluate the cytotoxicity of berberine, cell viability was ex-
amined. Compared with the control, the percentage of liv-
ing cells in 5, 25, and 50 μM of berberine was 93.6±4.1%, 
86.0±5.8%, 68.4±7.3%. In 25 μM berberine, there was 
no significant suppression by berberine on cell viability 
was observed compared to the control group. Therefore, 
we found that berberine directly suppressed IL-1β-in-
duced MUC5AC mRNA expression, not by its cytotoxicity. 
We used a berberine concentration of 25 μM for other ex-
periments.
Suppression of IL-1β-induced MUC5AC gene and 
protein expression by berberine 
NCI-H292 cells were pretreated with 25 μM berberine 
for 1 hour and then treated with 10 ng/mL of IL-1β. In com-
parison with the control that was not treated with either 
IL-1β or berberine, expression of MUC5AC mRNA in cells 
treated only with IL-1β increased by 4.8±0.7-fold, but in 
cells pretreated with berberine, the expression was signifi-
cantly decreased by 1.2±0.2-fold (p＜0.05)(Fig. 2A). In 
Western blot analysis, IL-1β induced expression of MU-
C5AC protein, but pretreatment with berberine decreased 
expression of IL-1β-induced MUC5AC protein to the 
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Fig. 1. Suppression of IL-1β-induced MUC5AC gene expression by 
berberine. RT-PCR (A) and real-time PCR (B) for MUC5AC mRNA 
expression show that expression of MUC5AC mRNA is signifi-
cantly suppressed after treatment with 25 µM of berberine in a 
dose-dependent manner. C : The percentage of living cells de-
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ERK- and p38 MAPK-dependent suppression of 
IL-1β-induced MUC5AC mRNA expression by 
berberine
To determine which MAPKs were activated in NCI-H292 
cells stimulated by IL-1β, we performed Western blot anal-
ysis using phospho-specific antibodies. ERK and p38 
MAPKs were maximally activated 30 minutes after treat-
ment with IL-1β, and this effect decreased after 60 minutes 
(Fig. 3A). Therefore, the incubation time to check changes 
in MAPK expression by berberine was determined as 30 
min. NCI-H292 cells were pretreated with 25 μM of ber-
berine for 1 hour, and then 10 ng/mL of IL-1β was added. 
After 30 min incubation, activation of p-ERK and p-p38 
MAPK was significantly decreased to the control level in 
comparison with the IL-1β alone-treated group (Fig. 3B). 
To confirm the possible involvement of the ERK and p38 
MAPK pathways in IL-1β-induced MUC5AC gene expres-
sion, 20 μM of PD98059 and 20 μM of SB203580 were 
separately added to cells 1 hour before their treatment with 
IL-1β. Pretreatment with PD98059 suppressed expression 
of p-ERK ; however, expressions of ERK and p-p38 re-
mained unchanged. Conversely, pretreatment with SB203580 
suppressed expression of p-p38, but p-ERK and ERK 
expressions did not change. These results showed that 
PD98059 and SB203580 clearly inhibited the ERK and 
p38 MAPK pathways, respectively (Fig. 4A). Under this 
experimental condition, we checked whether the ERK and 
p38 MAPK pathways were involved in the suppression 
of IL-1β-induced MUC5AC expression by berberine. When 
cells were treated with IL-1β only, the relative ratio of MU-
C5AC expression compared with the control was 5.0±
0.8. When specific inhibitors for ERK or p38 MAPK were 
added, the relative ratio of MUC5AC expression to the con-
trol was 1.3±0.2 for cells pretreated with PD98059 and 
0.9±0.3 for cells pretreated with SB203580. Thus, MU-
C5AC expression induced by IL-1β was significantly sup-
pressed by inhibiting the ERK or p38 MAPK signal trans-
duction pathways (p＜0.05)(Fig. 4B, C). These findings 
suggest that the ERK and p38 MAPK signaling pathways 



















Fig. 2. Suppression of IL-1β-induced MUC5AC gene and protein 
expressions by berberine. Cells were pretreated with 25 μM ber-
berine 1 hour before the addition of 10 ng/mL of IL-1β, and then 
real-time PCR (A) for MUC5AC mRNA expression and Western 
blot analysis (B) for MUC5AC protein were performed. A : Ex-
pression of MUC5AC mRNA increases in the presence of IL-1β, 
but the expression is significantly decreased to the control level 
by pretreatment with berberine (Berberine+IL-1β). B : Western 
blot analysis for MUC5AC protein expression. Expression of MU-
C5AC protein (arrow, 213 kDa) induced by IL-1β is suppressed 













Fig. 3. ERK and p38 mediate IL-1β-induced MUC5AC gene sup-
pression by berberine. A : Western blot analysis using phospho-
specific antibodies. Phosphorylation of ERK and p38 MAPK is 
maximally activated after 30 min, and this effect decreases af-
ter 60 min. B : Cells were pretreated with 25 mM berberine for 1 h, 
and then they were treated with 10 ng/mL of IL-1β (berberine+IL-1
β). After 30 min incubation, activation of p-ERK and p-p38 MAPK 
is significantly suppressed in berberine+IL-1β cells compared to 
IL-1β-only-treated cells. 
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C5AC has been reported to be associated with the patho-
genesis of chronic inflammatory airway diseases.12) Many 
cytokine mediators, including TNF-α, and bacterial prod-
ucts induce mucin gene expression in the airways. Since 
MUC5AC is up-regulated by TNF-α via NF-κB activa-
tion,13) we thought that berberine could be somewhat in-
volved in the down-regulation of MUC5AC expression, 
which we examined in this study. 
In this study, when cells were pretreated with 25 μM of 
berberine, expressions of MUC5AC mRNA and protein 
were significantly suppressed. This MUC5AC suppression 
were also observed in studies on [6]-gingerol, quercetin, 
curcumin, and EGCG.3)14) Berberine has been reported to 
inhibit protein synthesis and cell cycle progression and to 
induce apoptosis in different cancer cells.15) In this study, 
berberine had no cytotoxic effect on NCI-H292 cells at 25 
μM. These results indicate that berberine-induced suppres-
sion of MUC5AC expression was not the result of cytotox-
ic effects. Even though some polyphenols such as [6]-gin-
gerol, quercetin, curcumin, and EGCG suppress MUC5AC 
expression induced by IL-1β, the minimal concentrations 
to suppress MUC5AC expression are different.3)14) It may 
be due to the characteristic of the materials, and potency 
and toxicity of these polyphenols and berberine need to 
be examined before they could be clinically used.
To clarify the mechanism through which berberine sup-
presses IL-1β-induced MUC5AC gene expression, West-
ern blot analysis on MAPKs was done. MAPKs are impor-
tant enzymes in the production of mucin, and they also play 
a significant role in cell proliferation, differentiation, apop-
tosis, cytoskeletal remodeling, and cell cycle.16) In the pre-
vious study on the activation of MAPK by IL-1β, the in-
volvement of ERK and p38 MAPKs was revealed.3) In this 
study, ERK and p38 MAPKs which were activated by IL-
1β treatment were suppressed by the pretreatment with 25 
μM berberine. Therefore, we could infer that these MAPKs 
are involved in the regulation of MUC5AC suppression 
by berberine. To further investigate the involvement of 
ERK and p38 MAPKs, we performed the inhibitor study 
using specific inhibitors on ERK and p38 MAPKs. As a re-
sult, either the ERK- or p38 MAPK-specific inhibitors sup-
pressed IL-1β-induced MUC5AC gene expression. Thus, 
the ERK and p38 MAPK signal transduction pathways 
are involved in suppression of MUC5AC gene expres-
sion by berberine. In the study on [6]-gingerol, quercetin, 
and EGCG, MUC5AC expression was also suppressed.3)14) 
Thus, this finding coincides with our result regarding ber-
berine. However, there may be other pathways involved 
in the suppression of MUC5AC expression other than the 
DISCUSSION
Berberine is a quaternary ammonium salt from the group 
of isoquinoline alkaloids and is found in plants such as 
Berberis, goldenseal (Hydrastis canadenis), and Coptis 
chinensis in the roots, rhizomes, and stem bark. It has been 
known to have many pharmacological activities, includ-
ing anti-microbial and anti-inflammatory activities.5)6) 
Kuo et al. found that berberine could inhibit cyclooxygen-
ase-2 expression and prostaglandin E production by regu-
lating transcription factor activator protein 1.9) In addition, 
other studies showed that berberine induced IL-12 p40 
production by activating p38 MAPK and α2-adrenergic 
receptor in mouse macrophages, and deviates CD4+ T 
cell from a Th2 to a Th1 response.10)11) Recently, some stud-
ies showed that berberine can inhibit lipopolysaccharide 
(LPS)-stimulated myocardial TNF-α secretion and im-
proves LPS-induced contractile dysfunction in the intact 
heart.9) As mentioned, berberine shows many pharmaco-
logic activities, but there is no evidence that berberine can 
suppress mucin secretion in human airway epithelium. 























Fig. 4. Inhibition of ERK or p38 MAPK suppresses IL-1β-induced 
MUC5AC gene expression. NCI-H292 cells were separately pre-
treated for 1 hour with 20 μM PD98059 or 20 μM SB203580, and 
then stimulated for 24 hours with 10 ng/mL of IL-1β. A : Western 
blot analysis. PD98059 (PD+IL-1β) and SB203580 (SB+IL-1β) clearly 
inhibited p-ERK and p-p38 MAPK, respectively. B : Inhibition of 
either the ERK or p38 MAPK pathway with specific inhibitors sig-
nificantly suppresses MUC5AC gene expression in real-time PCR. 
The figures shown are representative of three independent ex-
periments. * : p＜0.05.
